PDRN for Acne Scars: How It Works, Evidence & Treatment Options

How PDRN Targets Acne Scars

PDRN addresses acne scars through targeted tissue regeneration at the dermal level. By binding to adenosine A2A receptors on fibroblasts within scar tissue, PDRN stimulates these cells to increase production of type I and type III collagen as well as glycosaminoglycans and other extracellular matrix components. This new matrix deposition gradually elevates depressed atrophic scars from beneath, improving surface contour without the need for filler material. PDRN's anti-inflammatory action is critical for scar remodeling — it downregulates TNF-alpha and IL-6 in chronically inflamed scar tissue, breaking the cycle of inflammation-driven fibrosis that prevents scars from maturing and flattening. Furthermore, PDRN promotes angiogenesis within the scar bed, improving blood supply to avascular scar tissue and enabling better delivery of nutrients needed for remodeling. The nucleotide fragments in PDRN also support DNA repair in damaged cells surrounding the scar, improving overall tissue health and function in the treated area.

PDRN (polydeoxyribonucleotide) has emerged as a powerful regenerative tool for acne scar treatment due to its ability to remodel damaged dermal tissue from the inside out. Unlike ablative procedures that work by creating controlled injury, PDRN directly stimulates the biological machinery of tissue repair through adenosine A2A receptor activation. This triggers fibroblasts to produce new collagen and extracellular matrix components in the scarred areas, gradually filling in atrophic depressions and smoothing the skin surface.

What makes PDRN particularly promising for acne scars is its dual action on both tissue regeneration and inflammation control. Residual chronic inflammation in scar tissue perpetuates fibrosis and prevents normal remodeling. PDRN suppresses pro-inflammatory cytokines and promotes the shift from inflammatory to reparative tissue states, creating conditions favorable for healthy collagen deposition rather than disorganized scar tissue formation.

Clinical experience from Korean dermatology clinics demonstrates that PDRN injections into acne scar tissue produce measurable improvements in scar depth and skin texture after 3-6 sessions. Results are enhanced when PDRN is combined with complementary procedures such as fractional laser or microneedling, where PDRN accelerates healing and improves the quality of new tissue formation. The treatment is well-tolerated across all skin types with minimal risk of hyperpigmentation.